Translational In Vivo Models for Cardiovascular Diseases

Area of Science:

• Cardiology
• Translational Medicine
• Preclinical Research

Background:

• Cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity globally.
• Effective in vitro and in vivo studies are essential for advancing experimental cardiology and preclinical drug development.
• Animal models have significantly improved understanding of CVD mechanisms, aiding diagnostic and therapeutic advancements.

Purpose of the Study:

• To highlight the importance of selecting appropriate animal models in cardiovascular research.
• To emphasize the challenges and opportunities in preclinical drug development for cardiac pathologies.
• To underscore the need for models that accurately mimic human pathophysiology for improved clinical translation.

Main Methods:

• Review of various animal models used in cardiovascular research across different species and sizes.
• Analysis of the limitations of current animal models in fully replicating complex cardiac diseases.
• Discussion on the criteria for selecting optimal animal models for specific cardiovascular conditions.

Main Results:

• Numerous animal models exist for studying heart failure, pulmonary hypertension, and thrombotic diseases.
• No single animal model perfectly replicates all aspects of human cardiovascular diseases due to complexity and heterogeneity.
• The selection of animal models that mirror critical features of human pathophysiology is key to successful translation.

Conclusions:

• Careful selection of animal models is vital for the success of cardiovascular drug development.
• Improved predictive value of preclinical models through accurate human pathophysiology reflection can lead to innovative treatments.
• Advancing diagnostic and therapeutic strategies for cardiovascular diseases relies on robust and relevant preclinical research.